284 related articles for article (PubMed ID: 27997977)
1. Regulation of Hepatocellular Fatty Acid Uptake in Mouse Models of Fatty Liver Disease with and without Functional Leptin Signaling: Roles of NfKB and SREBP-1C and the Effects of Spexin.
Ge JF; Walewski JL; Anglade D; Berk PD
Semin Liver Dis; 2016 Sep; 36(4):360-372. PubMed ID: 27997977
[TBL] [Abstract][Full Text] [Related]
2. Insulin- and leptin-regulated fatty acid uptake plays a key causal role in hepatic steatosis in mice with intact leptin signaling but not in ob/ob or db/db mice.
Ge F; Zhou S; Hu C; Lobdell H; Berk PD
Am J Physiol Gastrointest Liver Physiol; 2010 Oct; 299(4):G855-66. PubMed ID: 20595619
[TBL] [Abstract][Full Text] [Related]
3. Methionine restriction prevents the progression of hepatic steatosis in leptin-deficient obese mice.
Malloy VL; Perrone CE; Mattocks DA; Ables GP; Caliendo NS; Orentreich DS; Orentreich N
Metabolism; 2013 Nov; 62(11):1651-61. PubMed ID: 23928105
[TBL] [Abstract][Full Text] [Related]
4. Altered hepatic lipid metabolism contributes to nonalcoholic fatty liver disease in leptin-deficient Ob/Ob mice.
Perfield JW; Ortinau LC; Pickering RT; Ruebel ML; Meers GM; Rector RS
J Obes; 2013; 2013():296537. PubMed ID: 23401753
[TBL] [Abstract][Full Text] [Related]
5. Berberine attenuates nonalcoholic hepatic steatosis through the AMPK-SREBP-1c-SCD1 pathway.
Zhu X; Bian H; Wang L; Sun X; Xu X; Yan H; Xia M; Chang X; Lu Y; Li Y; Xia P; Li X; Gao X
Free Radic Biol Med; 2019 Sep; 141():192-204. PubMed ID: 31226399
[TBL] [Abstract][Full Text] [Related]
6. Spexin is a novel human peptide that reduces adipocyte uptake of long chain fatty acids and causes weight loss in rodents with diet-induced obesity.
Walewski JL; Ge F; Lobdell H; Levin N; Schwartz GJ; Vasselli JR; Pomp A; Dakin G; Berk PD
Obesity (Silver Spring); 2014 Jul; 22(7):1643-52. PubMed ID: 24550067
[TBL] [Abstract][Full Text] [Related]
7. 30-Day spexin treatment of mice with diet-induced obesity (DIO) and type 2 diabetes (T2DM) increases insulin sensitivity, improves liver functions and metabolic status.
Kolodziejski PA; Leciejewska N; Chmurzynska A; Sassek M; Szczepankiewicz A; Szczepankiewicz D; Malek E; Strowski MZ; Checinska-Maciejewska Z; Nowak KW; Pruszynska-Oszmalek E
Mol Cell Endocrinol; 2021 Oct; 536():111420. PubMed ID: 34384849
[TBL] [Abstract][Full Text] [Related]
8. Adiponectin homolog novel osmotin protects obesity/diabetes-induced NAFLD by upregulating AdipoRs/PPARα signaling in ob/ob and db/db transgenic mouse models.
Ahmad A; Ali T; Kim MW; Khan A; Jo MH; Rehman SU; Khan MS; Abid NB; Khan M; Ullah R; Jo MG; Kim MO
Metabolism; 2019 Jan; 90():31-43. PubMed ID: 30473057
[TBL] [Abstract][Full Text] [Related]
9. Nonalcoholic Fatty Liver Disease: Lipids and Insulin Resistance.
Berk PD; Verna EC
Clin Liver Dis; 2016 May; 20(2):245-62. PubMed ID: 27063267
[TBL] [Abstract][Full Text] [Related]
10. Crocin ameliorates hepatic steatosis through activation of AMPK signaling in db/db mice.
Luo L; Fang K; Dan X; Gu M
Lipids Health Dis; 2019 Jan; 18(1):11. PubMed ID: 30621686
[TBL] [Abstract][Full Text] [Related]
11. Artemisia scoparia extract attenuates non-alcoholic fatty liver disease in diet-induced obesity mice by enhancing hepatic insulin and AMPK signaling independently of FGF21 pathway.
Wang ZQ; Zhang XH; Yu Y; Tipton RC; Raskin I; Ribnicky D; Johnson W; Cefalu WT
Metabolism; 2013 Sep; 62(9):1239-49. PubMed ID: 23702383
[TBL] [Abstract][Full Text] [Related]
12. Treatment with spexin mitigates diet-induced hepatic steatosis in vivo and in vitro through activation of galanin receptor 2.
Wang M; Zhu Z; Kan Y; Yu M; Guo W; Ju M; Wang J; Yi S; Han S; Shang W; Zhang Z; Zhang L; Fang P
Mol Cell Endocrinol; 2022 Jul; 552():111688. PubMed ID: 35654225
[TBL] [Abstract][Full Text] [Related]
13. Degradation of PHLPP2 by KCTD17, via a Glucagon-Dependent Pathway, Promotes Hepatic Steatosis.
Kim K; Ryu D; Dongiovanni P; Ozcan L; Nayak S; Ueberheide B; Valenti L; Auwerx J; Pajvani UB
Gastroenterology; 2017 Dec; 153(6):1568-1580.e10. PubMed ID: 28859855
[TBL] [Abstract][Full Text] [Related]
14. Cardiotrophin-1 eliminates hepatic steatosis in obese mice by mechanisms involving AMPK activation.
Castaño D; Larequi E; Belza I; Astudillo AM; Martínez-Ansó E; Balsinde J; Argemi J; Aragon T; Moreno-Aliaga MJ; Muntane J; Prieto J; Bustos M
J Hepatol; 2014 May; 60(5):1017-25. PubMed ID: 24362075
[TBL] [Abstract][Full Text] [Related]
15. Thyroid hormone-responsive SPOT 14 homolog promotes hepatic lipogenesis, and its expression is regulated by liver X receptor α through a sterol regulatory element-binding protein 1c-dependent mechanism in mice.
Wu J; Wang C; Li S; Li S; Wang W; Li J; Chi Y; Yang H; Kong X; Zhou Y; Dong C; Wang F; Xu G; Yang J; Gustafsson JÅ; Guan Y
Hepatology; 2013 Aug; 58(2):617-28. PubMed ID: 23348573
[TBL] [Abstract][Full Text] [Related]
16. (S)YS-51, a novel isoquinoline alkaloid, attenuates obesity-associated non-alcoholic fatty liver disease in mice by suppressing lipogenesis, inflammation and coagulation.
Park EJ; Kim YM; Kim HJ; Jang SY; Oh MH; Lee DH; Chang KC
Eur J Pharmacol; 2016 Oct; 788():200-209. PubMed ID: 27343380
[TBL] [Abstract][Full Text] [Related]
17. SREBP-1c, regulated by the insulin and AMPK signaling pathways, plays a role in nonalcoholic fatty liver disease.
Kohjima M; Higuchi N; Kato M; Kotoh K; Yoshimoto T; Fujino T; Yada M; Yada R; Harada N; Enjoji M; Takayanagi R; Nakamuta M
Int J Mol Med; 2008 Apr; 21(4):507-11. PubMed ID: 18360697
[TBL] [Abstract][Full Text] [Related]
18. Ginsenosides reduce body weight and ameliorate hepatic steatosis in high fat diet‑induced obese mice via endoplasmic reticulum stress and p‑STAT3/STAT3 signaling.
Yao Y
Mol Med Rep; 2020 Mar; 21(3):1059-1070. PubMed ID: 32016448
[TBL] [Abstract][Full Text] [Related]
19. Lycopus lucidus Turcz. ex Benth. Attenuates free fatty acid-induced steatosis in HepG2 cells and non-alcoholic fatty liver disease in high-fat diet-induced obese mice.
Lee MR; Yang HJ; Park KI; Ma JY
Phytomedicine; 2019 Mar; 55():14-22. PubMed ID: 30668424
[TBL] [Abstract][Full Text] [Related]
20. Restoration of the ER stress response protein TDAG51 in hepatocytes mitigates NAFLD in mice.
Yousof TR; Bouchard CC; Alb M; Lynn EG; Lhoták S; Jiang H; MacDonald M; Li H; Byun JH; Makda Y; Athanasopoulos M; Maclean KN; Cherrington NJ; Naqvi A; Igdoura SA; Krepinsky JC; Steinberg GR; Austin RC
J Biol Chem; 2024 Feb; 300(2):105655. PubMed ID: 38237682
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
